PT854924E - Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose - Google Patents

Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose

Info

Publication number
PT854924E
PT854924E PT96933854T PT96933854T PT854924E PT 854924 E PT854924 E PT 854924E PT 96933854 T PT96933854 T PT 96933854T PT 96933854 T PT96933854 T PT 96933854T PT 854924 E PT854924 E PT 854924E
Authority
PT
Portugal
Prior art keywords
therapy
leishmaniose
diagnosis
leishmania antigens
leishmania
Prior art date
Application number
PT96933854T
Other languages
English (en)
Inventor
Steven G Reed
Yasir A W Skeiky
Davin C Dillon
Antonio Campos-Neto
John R Webb
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of PT854924E publication Critical patent/PT854924E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT96933854T 1995-09-22 1996-09-20 Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose PT854924E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/533,669 US5834592A (en) 1995-09-22 1995-09-22 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis

Publications (1)

Publication Number Publication Date
PT854924E true PT854924E (pt) 2003-11-28

Family

ID=24126960

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96933854T PT854924E (pt) 1995-09-22 1996-09-20 Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose

Country Status (9)

Country Link
US (2) US5834592A (pt)
EP (1) EP0854924B1 (pt)
AT (1) ATE243750T1 (pt)
AU (1) AU7242796A (pt)
BR (1) BRPI9610679B1 (pt)
DE (1) DE69628844T2 (pt)
ES (1) ES2205059T3 (pt)
PT (1) PT854924E (pt)
WO (1) WO1997011180A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013268A (en) * 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6613337B1 (en) * 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en) 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6365165B1 (en) 1995-09-22 2002-04-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6607731B1 (en) 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6638517B2 (en) 1995-09-22 2003-10-28 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
EP2284186A1 (en) * 1997-02-12 2011-02-16 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
ATE530651T1 (de) * 1997-02-12 2011-11-15 Corixa Corp Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
US20040241168A1 (en) * 2001-03-16 2004-12-02 O'daly Jose A. Compositions and methods for the treatment and clinical remission of psoriasis
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
CN1973049A (zh) * 2003-12-23 2007-05-30 全印度医疗科学学会 用于检测利什曼病的寡核苷酸及其方法
ATE457316T1 (de) * 2003-12-26 2010-02-15 All India Inst Med Polypeptide zur diagnose und therapie von leishmaniasen
WO2007121184A2 (en) 2006-04-10 2007-10-25 The Infectious Disease Research Institute Inc. Compounds and methods for diagnosis and treatment of leishmaniasis
US8231881B2 (en) 2008-07-03 2012-07-31 Infectious Disease Research Institute Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
BR112015024860B1 (pt) 2013-03-28 2023-11-07 Access To Advanced Health Institute Polipeptídeo de fusão, polinucleotídeo isolado, composição compreendendo dito polipeptídeo, uso da dita composição para estimular uma resposta imune contra leishmania e método in vitro e kit de diagnóstico para detectar infecção por leishmania em uma amostra biológica
WO2015171395A2 (en) * 2014-05-05 2015-11-12 Purdue Research Foundation Degradation resistant peptide based biosensors
TR202006914A1 (tr) * 2020-05-04 2021-11-22 Univ Yeditepe İmmunoprofi̇lakti̇k ve i̇mmunoterapöti̇k olarak ekstraselüler vezi̇külleri̇ni̇n lei̇shmani̇asi̇s hastaliği i̇çi̇n kullanimi
FR3115681A1 (fr) 2020-11-04 2022-05-06 Vaxinano Vaccin therapeutique comprenant un antigene specifique d’une maladie n’atteignant pas le systeme nerveux central et des nanoparticules et son utilisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) * 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
JP3350551B2 (ja) * 1994-04-22 2002-11-25 コリクサ コーポレイション 保護的免疫応答及びｉｌ−１２産生の刺激及び促進のための化合物及び方法
US6013268A (en) * 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
US5876735A (en) * 1994-04-22 1999-03-02 Corixa Corporation Methods for enhancement of protective immune responses
US5965142A (en) * 1995-08-04 1999-10-12 Corixa Corporation Polypeptides and methods for the detection of L. tropica infection
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6054135A (en) * 1996-11-14 2000-04-25 Corixa Compounds and methods for the detection and prevention of T. cruzi infection
US5744593A (en) * 1996-02-15 1998-04-28 Heska Corporation Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules

Also Published As

Publication number Publication date
ATE243750T1 (de) 2003-07-15
DE69628844T2 (de) 2004-05-19
BR9610679A (pt) 1999-03-30
EP0854924A1 (en) 1998-07-29
US5834592A (en) 1998-11-10
EP0854924B1 (en) 2003-06-25
WO1997011180A1 (en) 1997-03-27
MX9802284A (es) 1998-08-30
US6709661B1 (en) 2004-03-23
BRPI9610679B1 (pt) 2017-05-16
ES2205059T3 (es) 2004-05-01
AU7242796A (en) 1997-04-09
DE69628844D1 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
PT854924E (pt) Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose
PT1203817E (pt) Compostos e metodos para imunoterapia e le diagnostic de tuberculose
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ATE126706T1 (de) Hauttest und testkit für aids.
AU2210899A (en) Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
EP2172551A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
AU7814498A (en) Multivalent (in ovo) avian vaccine
ATE306938T1 (de) Verwendung von cpg als adjuvans für hivimpstoff
MXPA02010173A (es) Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.
WO1998035045A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
DE10075036I2 (de) Impfstoff und Diagnostikum f}r den Schweine-Cholera-Virus.
NO912942D0 (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
WO2002098359A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
EP1422238A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
NO892015L (no) Fremgangsmaate for fremstilling av et legemiddel.
AU5061090A (en) Aids therapy
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
IT8919574A0 (it) Procedimento ed impianto per la preparazione di prodotti farmaceutici in genere.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
GB9618119D0 (en) Adjuvants for use in vaccines
ES1011091Y (es) Dispositivo de extraccion de protesis dentales, coronas y similares.
GR3031499T3 (en) Hog cholera virus vaccine and diagnostic.
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.